img

Global Broad-spectrum Antibiotics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Broad-spectrum Antibiotics Market Insights, Forecast to 2034

Global Broad-spectrum Antibiotics market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Broad-spectrum Antibiotics industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Broad-spectrum Antibiotics key manufacturers include Hanmi Cepha Plant, Globela Pharma, Allergan Plc, Bristol-Myers Squibb Company, F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc, Novartis International AG, Pfizer Inc and Sanofi, and Teva Pharmaceutical Industries Ltd, etc. Hanmi Cepha Plant, Globela Pharma, Allergan Plc are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Broad-spectrum Antibiotics were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Broad-spectrum Antibiotics market and estimated to attract more attentions from industry insiders and investors.
Broad-spectrum Antibiotics can be divided into Cephalosporins, Penicillins, Carbapenems and Tetracyclines, etc. Cephalosporins is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Broad-spectrum Antibiotics is widely used in various fields, such as Hospital and Pharmacy, etc. Hospital provides greatest supports to the Broad-spectrum Antibiotics industry development. In 2022, global % sales of Broad-spectrum Antibiotics went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Broad-spectrum Antibiotics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Broad-spectrum Antibiotics market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Hanmi Cepha Plant
Globela Pharma
Allergan Plc
Bristol-Myers Squibb Company
F.Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Merck & Co. Inc
Novartis International AG, Pfizer Inc
Sanofi, and Teva Pharmaceutical Industries Ltd
NextPharma
Segment by Type
Cephalosporins
Penicillins
Carbapenems
Tetracyclines
Chloramphenicol
Others

Segment by Application


Hospital
Pharmacy

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Broad-spectrum Antibiotics plant distribution, commercial date of Broad-spectrum Antibiotics, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Broad-spectrum Antibiotics introduction, etc. Broad-spectrum Antibiotics Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Broad-spectrum Antibiotics
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Broad-spectrum Antibiotics Product Introduction
1.2 Market by Type
1.2.1 Global Broad-spectrum Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cephalosporins
1.2.3 Penicillins
1.2.4 Carbapenems
1.2.5 Tetracyclines
1.2.6 Chloramphenicol
1.2.7 Others
1.3 Market by Application
1.3.1 Global Broad-spectrum Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Broad-spectrum Antibiotics Sales Estimates and Forecasts 2018-2029
2.2 Global Broad-spectrum Antibiotics Revenue by Region
2.2.1 Global Broad-spectrum Antibiotics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Broad-spectrum Antibiotics Revenue by Region (2018-2024)
2.2.3 Global Broad-spectrum Antibiotics Revenue by Region (2024-2029)
2.2.4 Global Broad-spectrum Antibiotics Revenue Market Share by Region (2018-2029)
2.3 Global Broad-spectrum Antibiotics Sales Estimates and Forecasts 2018-2029
2.4 Global Broad-spectrum Antibiotics Sales by Region
2.4.1 Global Broad-spectrum Antibiotics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Broad-spectrum Antibiotics Sales by Region (2018-2024)
2.4.3 Global Broad-spectrum Antibiotics Sales by Region (2024-2029)
2.4.4 Global Broad-spectrum Antibiotics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Broad-spectrum Antibiotics Sales by Manufacturers
3.1.1 Global Broad-spectrum Antibiotics Sales by Manufacturers (2018-2024)
3.1.2 Global Broad-spectrum Antibiotics Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Broad-spectrum Antibiotics in 2022
3.2 Global Broad-spectrum Antibiotics Revenue by Manufacturers
3.2.1 Global Broad-spectrum Antibiotics Revenue by Manufacturers (2018-2024)
3.2.2 Global Broad-spectrum Antibiotics Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Broad-spectrum Antibiotics Revenue in 2022
3.3 Global Key Players of Broad-spectrum Antibiotics, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Broad-spectrum Antibiotics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Broad-spectrum Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Broad-spectrum Antibiotics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Broad-spectrum Antibiotics, Product Offered and Application
3.8 Global Key Manufacturers of Broad-spectrum Antibiotics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Broad-spectrum Antibiotics Sales by Type
4.1.1 Global Broad-spectrum Antibiotics Historical Sales by Type (2018-2024)
4.1.2 Global Broad-spectrum Antibiotics Forecasted Sales by Type (2024-2029)
4.1.3 Global Broad-spectrum Antibiotics Sales Market Share by Type (2018-2029)
4.2 Global Broad-spectrum Antibiotics Revenue by Type
4.2.1 Global Broad-spectrum Antibiotics Historical Revenue by Type (2018-2024)
4.2.2 Global Broad-spectrum Antibiotics Forecasted Revenue by Type (2024-2029)
4.2.3 Global Broad-spectrum Antibiotics Revenue Market Share by Type (2018-2029)
4.3 Global Broad-spectrum Antibiotics Price by Type
4.3.1 Global Broad-spectrum Antibiotics Price by Type (2018-2024)
4.3.2 Global Broad-spectrum Antibiotics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Broad-spectrum Antibiotics Sales by Application
5.1.1 Global Broad-spectrum Antibiotics Historical Sales by Application (2018-2024)
5.1.2 Global Broad-spectrum Antibiotics Forecasted Sales by Application (2024-2029)
5.1.3 Global Broad-spectrum Antibiotics Sales Market Share by Application (2018-2029)
5.2 Global Broad-spectrum Antibiotics Revenue by Application
5.2.1 Global Broad-spectrum Antibiotics Historical Revenue by Application (2018-2024)
5.2.2 Global Broad-spectrum Antibiotics Forecasted Revenue by Application (2024-2029)
5.2.3 Global Broad-spectrum Antibiotics Revenue Market Share by Application (2018-2029)
5.3 Global Broad-spectrum Antibiotics Price by Application
5.3.1 Global Broad-spectrum Antibiotics Price by Application (2018-2024)
5.3.2 Global Broad-spectrum Antibiotics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Broad-spectrum Antibiotics Market Size by Type
6.1.1 US & Canada Broad-spectrum Antibiotics Sales by Type (2018-2029)
6.1.2 US & Canada Broad-spectrum Antibiotics Revenue by Type (2018-2029)
6.2 US & Canada Broad-spectrum Antibiotics Market Size by Application
6.2.1 US & Canada Broad-spectrum Antibiotics Sales by Application (2018-2029)
6.2.2 US & Canada Broad-spectrum Antibiotics Revenue by Application (2018-2029)
6.3 US & Canada Broad-spectrum Antibiotics Market Size by Country
6.3.1 US & Canada Broad-spectrum Antibiotics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Broad-spectrum Antibiotics Sales by Country (2018-2029)
6.3.3 US & Canada Broad-spectrum Antibiotics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Broad-spectrum Antibiotics Market Size by Type
7.1.1 Europe Broad-spectrum Antibiotics Sales by Type (2018-2029)
7.1.2 Europe Broad-spectrum Antibiotics Revenue by Type (2018-2029)
7.2 Europe Broad-spectrum Antibiotics Market Size by Application
7.2.1 Europe Broad-spectrum Antibiotics Sales by Application (2018-2029)
7.2.2 Europe Broad-spectrum Antibiotics Revenue by Application (2018-2029)
7.3 Europe Broad-spectrum Antibiotics Market Size by Country
7.3.1 Europe Broad-spectrum Antibiotics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Broad-spectrum Antibiotics Sales by Country (2018-2029)
7.3.3 Europe Broad-spectrum Antibiotics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Broad-spectrum Antibiotics Market Size
8.1.1 China Broad-spectrum Antibiotics Sales (2018-2029)
8.1.2 China Broad-spectrum Antibiotics Revenue (2018-2029)
8.2 China Broad-spectrum Antibiotics Market Size by Application
8.2.1 China Broad-spectrum Antibiotics Sales by Application (2018-2029)
8.2.2 China Broad-spectrum Antibiotics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Broad-spectrum Antibiotics Market Size by Type
9.1.1 Asia Broad-spectrum Antibiotics Sales by Type (2018-2029)
9.1.2 Asia Broad-spectrum Antibiotics Revenue by Type (2018-2029)
9.2 Asia Broad-spectrum Antibiotics Market Size by Application
9.2.1 Asia Broad-spectrum Antibiotics Sales by Application (2018-2029)
9.2.2 Asia Broad-spectrum Antibiotics Revenue by Application (2018-2029)
9.3 Asia Broad-spectrum Antibiotics Sales by Region
9.3.1 Asia Broad-spectrum Antibiotics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Broad-spectrum Antibiotics Revenue by Region (2018-2029)
9.3.3 Asia Broad-spectrum Antibiotics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Broad-spectrum Antibiotics Market Size by Type
10.1.1 Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Broad-spectrum Antibiotics Market Size by Application
10.2.1 Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Country
10.3.1 Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Hanmi Cepha Plant
11.1.1 Hanmi Cepha Plant Company Information
11.1.2 Hanmi Cepha Plant Overview
11.1.3 Hanmi Cepha Plant Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Hanmi Cepha Plant Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hanmi Cepha Plant Recent Developments
11.2 Globela Pharma
11.2.1 Globela Pharma Company Information
11.2.2 Globela Pharma Overview
11.2.3 Globela Pharma Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Globela Pharma Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Globela Pharma Recent Developments
11.3 Allergan Plc
11.3.1 Allergan Plc Company Information
11.3.2 Allergan Plc Overview
11.3.3 Allergan Plc Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Allergan Plc Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Allergan Plc Recent Developments
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Information
11.4.2 Bristol-Myers Squibb Company Overview
11.4.3 Bristol-Myers Squibb Company Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Bristol-Myers Squibb Company Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bristol-Myers Squibb Company Recent Developments
11.5 F.Hoffmann-La Roche Ltd.
11.5.1 F.Hoffmann-La Roche Ltd. Company Information
11.5.2 F.Hoffmann-La Roche Ltd. Overview
11.5.3 F.Hoffmann-La Roche Ltd. Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 F.Hoffmann-La Roche Ltd. Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F.Hoffmann-La Roche Ltd. Recent Developments
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Company Information
11.6.2 GlaxoSmithKline Plc Overview
11.6.3 GlaxoSmithKline Plc Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 GlaxoSmithKline Plc Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Plc Recent Developments
11.7 Merck & Co. Inc
11.7.1 Merck & Co. Inc Company Information
11.7.2 Merck & Co. Inc Overview
11.7.3 Merck & Co. Inc Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Merck & Co. Inc Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck & Co. Inc Recent Developments
11.8 Novartis International AG, Pfizer Inc
11.8.1 Novartis International AG, Pfizer Inc Company Information
11.8.2 Novartis International AG, Pfizer Inc Overview
11.8.3 Novartis International AG, Pfizer Inc Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Novartis International AG, Pfizer Inc Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis International AG, Pfizer Inc Recent Developments
11.9 Sanofi, and Teva Pharmaceutical Industries Ltd
11.9.1 Sanofi, and Teva Pharmaceutical Industries Ltd Company Information
11.9.2 Sanofi, and Teva Pharmaceutical Industries Ltd Overview
11.9.3 Sanofi, and Teva Pharmaceutical Industries Ltd Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sanofi, and Teva Pharmaceutical Industries Ltd Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi, and Teva Pharmaceutical Industries Ltd Recent Developments
11.10 NextPharma
11.10.1 NextPharma Company Information
11.10.2 NextPharma Overview
11.10.3 NextPharma Broad-spectrum Antibiotics Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 NextPharma Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 NextPharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Broad-spectrum Antibiotics Industry Chain Analysis
12.2 Broad-spectrum Antibiotics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Broad-spectrum Antibiotics Production Mode & Process
12.4 Broad-spectrum Antibiotics Sales and Marketing
12.4.1 Broad-spectrum Antibiotics Sales Channels
12.4.2 Broad-spectrum Antibiotics Distributors
12.5 Broad-spectrum Antibiotics Customers
13 Market Dynamics
13.1 Broad-spectrum Antibiotics Industry Trends
13.2 Broad-spectrum Antibiotics Market Drivers
13.3 Broad-spectrum Antibiotics Market Challenges
13.4 Broad-spectrum Antibiotics Market Restraints
14 Key Findings in The Global Broad-spectrum Antibiotics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Broad-spectrum Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Cephalosporins
Table 3. Major Manufacturers of Penicillins
Table 4. Major Manufacturers of Carbapenems
Table 5. Major Manufacturers of Tetracyclines
Table 6. Major Manufacturers of Chloramphenicol
Table 7. Major Manufacturers of Others
Table 8. Global Broad-spectrum Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Broad-spectrum Antibiotics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Broad-spectrum Antibiotics Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Broad-spectrum Antibiotics Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Broad-spectrum Antibiotics Revenue Market Share by Region (2018-2024)
Table 13. Global Broad-spectrum Antibiotics Revenue Market Share by Region (2024-2029)
Table 14. Global Broad-spectrum Antibiotics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Broad-spectrum Antibiotics Sales by Region (2018-2024) & (K Units)
Table 16. Global Broad-spectrum Antibiotics Sales by Region (2024-2029) & (K Units)
Table 17. Global Broad-spectrum Antibiotics Sales Market Share by Region (2018-2024)
Table 18. Global Broad-spectrum Antibiotics Sales Market Share by Region (2024-2029)
Table 19. Global Broad-spectrum Antibiotics Sales by Manufacturers (2018-2024) & (K Units)
Table 20. Global Broad-spectrum Antibiotics Sales Share by Manufacturers (2018-2024)
Table 21. Global Broad-spectrum Antibiotics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Broad-spectrum Antibiotics Revenue Share by Manufacturers (2018-2024)
Table 23. Global Key Players of Broad-spectrum Antibiotics, Industry Ranking, 2021 VS 2022 VS 2024
Table 24. Broad-spectrum Antibiotics Price by Manufacturers 2018-2024 (US$/Unit)
Table 25. Global Broad-spectrum Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Broad-spectrum Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Broad-spectrum Antibiotics as of 2022)
Table 27. Global Key Manufacturers of Broad-spectrum Antibiotics, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Broad-spectrum Antibiotics, Product Offered and Application
Table 29. Global Key Manufacturers of Broad-spectrum Antibiotics, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Broad-spectrum Antibiotics Sales by Type (2018-2024) & (K Units)
Table 32. Global Broad-spectrum Antibiotics Sales by Type (2024-2029) & (K Units)
Table 33. Global Broad-spectrum Antibiotics Sales Share by Type (2018-2024)
Table 34. Global Broad-spectrum Antibiotics Sales Share by Type (2024-2029)
Table 35. Global Broad-spectrum Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Broad-spectrum Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Broad-spectrum Antibiotics Revenue Share by Type (2018-2024)
Table 38. Global Broad-spectrum Antibiotics Revenue Share by Type (2024-2029)
Table 39. Broad-spectrum Antibiotics Price by Type (2018-2024) & (US$/Unit)
Table 40. Global Broad-spectrum Antibiotics Price Forecast by Type (2024-2029) & (US$/Unit)
Table 41. Global Broad-spectrum Antibiotics Sales by Application (2018-2024) & (K Units)
Table 42. Global Broad-spectrum Antibiotics Sales by Application (2024-2029) & (K Units)
Table 43. Global Broad-spectrum Antibiotics Sales Share by Application (2018-2024)
Table 44. Global Broad-spectrum Antibiotics Sales Share by Application (2024-2029)
Table 45. Global Broad-spectrum Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Broad-spectrum Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Broad-spectrum Antibiotics Revenue Share by Application (2018-2024)
Table 48. Global Broad-spectrum Antibiotics Revenue Share by Application (2024-2029)
Table 49. Broad-spectrum Antibiotics Price by Application (2018-2024) & (US$/Unit)
Table 50. Global Broad-spectrum Antibiotics Price Forecast by Application (2024-2029) & (US$/Unit)
Table 51. US & Canada Broad-spectrum Antibiotics Sales by Type (2018-2024) & (K Units)
Table 52. US & Canada Broad-spectrum Antibiotics Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Broad-spectrum Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 54. US & Canada Broad-spectrum Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Broad-spectrum Antibiotics Sales by Application (2018-2024) & (K Units)
Table 56. US & Canada Broad-spectrum Antibiotics Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Broad-spectrum Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 58. US & Canada Broad-spectrum Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Broad-spectrum Antibiotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Broad-spectrum Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 61. US & Canada Broad-spectrum Antibiotics Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Broad-spectrum Antibiotics Sales by Country (2018-2024) & (K Units)
Table 63. US & Canada Broad-spectrum Antibiotics Sales by Country (2024-2029) & (K Units)
Table 64. Europe Broad-spectrum Antibiotics Sales by Type (2018-2024) & (K Units)
Table 65. Europe Broad-spectrum Antibiotics Sales by Type (2024-2029) & (K Units)
Table 66. Europe Broad-spectrum Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Broad-spectrum Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Broad-spectrum Antibiotics Sales by Application (2018-2024) & (K Units)
Table 69. Europe Broad-spectrum Antibiotics Sales by Application (2024-2029) & (K Units)
Table 70. Europe Broad-spectrum Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Broad-spectrum Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Broad-spectrum Antibiotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Broad-spectrum Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Broad-spectrum Antibiotics Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Broad-spectrum Antibiotics Sales by Country (2018-2024) & (K Units)
Table 76. Europe Broad-spectrum Antibiotics Sales by Country (2024-2029) & (K Units)
Table 77. China Broad-spectrum Antibiotics Sales by Type (2018-2024) & (K Units)
Table 78. China Broad-spectrum Antibiotics Sales by Type (2024-2029) & (K Units)
Table 79. China Broad-spectrum Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 80. China Broad-spectrum Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Broad-spectrum Antibiotics Sales by Application (2018-2024) & (K Units)
Table 82. China Broad-spectrum Antibiotics Sales by Application (2024-2029) & (K Units)
Table 83. China Broad-spectrum Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 84. China Broad-spectrum Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Broad-spectrum Antibiotics Sales by Type (2018-2024) & (K Units)
Table 86. Asia Broad-spectrum Antibiotics Sales by Type (2024-2029) & (K Units)
Table 87. Asia Broad-spectrum Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 88. Asia Broad-spectrum Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Broad-spectrum Antibiotics Sales by Application (2018-2024) & (K Units)
Table 90. Asia Broad-spectrum Antibiotics Sales by Application (2024-2029) & (K Units)
Table 91. Asia Broad-spectrum Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 92. Asia Broad-spectrum Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Broad-spectrum Antibiotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Broad-spectrum Antibiotics Revenue by Region (2018-2024) & (US$ Million)
Table 95. Asia Broad-spectrum Antibiotics Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Broad-spectrum Antibiotics Sales by Region (2018-2024) & (K Units)
Table 97. Asia Broad-spectrum Antibiotics Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Type (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Application (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Country (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales by Country (2024-2029) & (K Units)
Table 111. Hanmi Cepha Plant Company Information
Table 112. Hanmi Cepha Plant Description and Major Businesses
Table 113. Hanmi Cepha Plant Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 114. Hanmi Cepha Plant Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Hanmi Cepha Plant Recent Developments
Table 116. Globela Pharma Company Information
Table 117. Globela Pharma Description and Major Businesses
Table 118. Globela Pharma Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 119. Globela Pharma Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Globela Pharma Recent Developments
Table 121. Allergan Plc Company Information
Table 122. Allergan Plc Description and Major Businesses
Table 123. Allergan Plc Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 124. Allergan Plc Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Allergan Plc Recent Developments
Table 126. Bristol-Myers Squibb Company Company Information
Table 127. Bristol-Myers Squibb Company Description and Major Businesses
Table 128. Bristol-Myers Squibb Company Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 129. Bristol-Myers Squibb Company Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Bristol-Myers Squibb Company Recent Developments
Table 131. F.Hoffmann-La Roche Ltd. Company Information
Table 132. F.Hoffmann-La Roche Ltd. Description and Major Businesses
Table 133. F.Hoffmann-La Roche Ltd. Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 134. F.Hoffmann-La Roche Ltd. Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. F.Hoffmann-La Roche Ltd. Recent Developments
Table 136. GlaxoSmithKline Plc Company Information
Table 137. GlaxoSmithKline Plc Description and Major Businesses
Table 138. GlaxoSmithKline Plc Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 139. GlaxoSmithKline Plc Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. GlaxoSmithKline Plc Recent Developments
Table 141. Merck & Co. Inc Company Information
Table 142. Merck & Co. Inc Description and Major Businesses
Table 143. Merck & Co. Inc Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 144. Merck & Co. Inc Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Merck & Co. Inc Recent Developments
Table 146. Novartis International AG, Pfizer Inc Company Information
Table 147. Novartis International AG, Pfizer Inc Description and Major Businesses
Table 148. Novartis International AG, Pfizer Inc Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 149. Novartis International AG, Pfizer Inc Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Novartis International AG, Pfizer Inc Recent Developments
Table 151. Sanofi, and Teva Pharmaceutical Industries Ltd Company Information
Table 152. Sanofi, and Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 153. Sanofi, and Teva Pharmaceutical Industries Ltd Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 154. Sanofi, and Teva Pharmaceutical Industries Ltd Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Sanofi, and Teva Pharmaceutical Industries Ltd Recent Developments
Table 156. NextPharma Company Information
Table 157. NextPharma Description and Major Businesses
Table 158. NextPharma Broad-spectrum Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 159. NextPharma Broad-spectrum Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. NextPharma Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Broad-spectrum Antibiotics Distributors List
Table 164. Broad-spectrum Antibiotics Customers List
Table 165. Broad-spectrum Antibiotics Market Trends
Table 166. Broad-spectrum Antibiotics Market Drivers
Table 167. Broad-spectrum Antibiotics Market Challenges
Table 168. Broad-spectrum Antibiotics Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Broad-spectrum Antibiotics Product Picture
Figure 2. Global Broad-spectrum Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Broad-spectrum Antibiotics Market Share by Type in 2022 & 2029
Figure 4. Cephalosporins Product Picture
Figure 5. Penicillins Product Picture
Figure 6. Carbapenems Product Picture
Figure 7. Tetracyclines Product Picture
Figure 8. Chloramphenicol Product Picture
Figure 9. Others Product Picture
Figure 10. Global Broad-spectrum Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Broad-spectrum Antibiotics Market Share by Application in 2022 & 2029
Figure 12. Hospital
Figure 13. Pharmacy
Figure 14. Broad-spectrum Antibiotics Report Years Considered
Figure 15. Global Broad-spectrum Antibiotics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Broad-spectrum Antibiotics Revenue 2018-2029 (US$ Million)
Figure 17. Global Broad-spectrum Antibiotics Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Broad-spectrum Antibiotics Revenue Market Share by Region (2018-2029)
Figure 19. Global Broad-spectrum Antibiotics Sales 2018-2029 ((K Units)
Figure 20. Global Broad-spectrum Antibiotics Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Broad-spectrum Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Broad-spectrum Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Broad-spectrum Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Broad-spectrum Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Broad-spectrum Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 26. China Broad-spectrum Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Broad-spectrum Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Broad-spectrum Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Broad-spectrum Antibiotics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Broad-spectrum Antibiotics in the World: Market Share by Broad-spectrum Antibiotics Revenue in 2022
Figure 33. Global Broad-spectrum Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Broad-spectrum Antibiotics Sales Market Share by Type (2018-2029)
Figure 35. Global Broad-spectrum Antibiotics Revenue Market Share by Type (2018-2029)
Figure 36. Global Broad-spectrum Antibiotics Sales Market Share by Application (2018-2029)
Figure 37. Global Broad-spectrum Antibiotics Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Broad-spectrum Antibiotics Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Broad-spectrum Antibiotics Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Broad-spectrum Antibiotics Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Broad-spectrum Antibiotics Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Broad-spectrum Antibiotics Revenue Share by Country (2018-2029)
Figure 43. US & Canada Broad-spectrum Antibiotics Sales Share by Country (2018-2029)
Figure 44. U.S. Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Broad-spectrum Antibiotics Sales Market Share by Type (2018-2029)
Figure 47. Europe Broad-spectrum Antibiotics Revenue Market Share by Type (2018-2029)
Figure 48. Europe Broad-spectrum Antibiotics Sales Market Share by Application (2018-2029)
Figure 49. Europe Broad-spectrum Antibiotics Revenue Market Share by Application (2018-2029)
Figure 50. Europe Broad-spectrum Antibiotics Revenue Share by Country (2018-2029)
Figure 51. Europe Broad-spectrum Antibiotics Sales Share by Country (2018-2029)
Figure 52. Germany Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 53. France Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 57. China Broad-spectrum Antibiotics Sales Market Share by Type (2018-2029)
Figure 58. China Broad-spectrum Antibiotics Revenue Market Share by Type (2018-2029)
Figure 59. China Broad-spectrum Antibiotics Sales Market Share by Application (2018-2029)
Figure 60. China Broad-spectrum Antibiotics Revenue Market Share by Application (2018-2029)
Figure 61. Asia Broad-spectrum Antibiotics Sales Market Share by Type (2018-2029)
Figure 62. Asia Broad-spectrum Antibiotics Revenue Market Share by Type (2018-2029)
Figure 63. Asia Broad-spectrum Antibiotics Sales Market Share by Application (2018-2029)
Figure 64. Asia Broad-spectrum Antibiotics Revenue Market Share by Application (2018-2029)
Figure 65. Asia Broad-spectrum Antibiotics Revenue Share by Region (2018-2029)
Figure 66. Asia Broad-spectrum Antibiotics Sales Share by Region (2018-2029)
Figure 67. Japan Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 71. India Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Broad-spectrum Antibiotics Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Broad-spectrum Antibiotics Sales Share by Country (2018-2029)
Figure 78. Brazil Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Broad-spectrum Antibiotics Revenue (2018-2029) & (US$ Million)
Figure 83. Broad-spectrum Antibiotics Value Chain
Figure 84. Broad-spectrum Antibiotics Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries